In all tumors we examined, treatment with 5-Ph-IAA led to a complete degradation of the cognate target (Fig. 6C), and this result was further confirmed by performing immunohistochemistry (IHC) for UHRF1 on tumor sections (Supplementary Fig. 6C, D). This evidence concerns the gene UHRF1 and neoplasm.